ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726858 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726858; 2) Community: the network communities that were significantly associated with the response to NSC 726858; 3) Molecule: the relationships between components within communities and NSC 726858; 4) MDR: the compounds that were significantly associated with the NSC 726858.

NSC Compound Enrichment Correlation
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.00313644776247638 0.27605117
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.00313644776247638 0.40638815
NSC 382049 2,4-Pyrimidinediamine, 6-ethyl-5-[3-nitro- 4-[(2-phenylethyl)amino]phenyl]- 0.00313644776247638 0.2331021
NSC 620687 Null 0.00313644776247638 0.38501218
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.00313644776247638 0.42237624
NSC 628115 9-N(N'-chloroethyl-N'-methyl-1,2-diaminoethyl) 2 methoxyacridine dihydrochloride 0.00313644776247638 0.18356407
NSC 630602 1-Piperidinecarboxylic acid, 4-oxo-3,5-bis(phenyl- methylene)-, ethyl ester 0.00313644776247638 0.36337408
NSC 637507 Null 0.00313644776247638 0.36034219
NSC 643486 Null 0.00313644776247638 0.47643416
NSC 648265 [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin 0.00313644776247638 0.43743718
Total:115  Current:16    [First] [Prev] [Next] [Last]